Risk of bias versus quality assessment of randomised controlled trials: cross sectional study
Top Cited Papers
Open Access
- 19 October 2009
- Vol. 339 (oct19 1) , b4012
- https://doi.org/10.1136/bmj.b4012
Abstract
Objectives To evaluate the risk of bias tool, introduced by the Cochrane Collaboration for assessing the internal validity of randomised trials, for inter-rater agreement, concurrent validity compared with the Jadad scale and Schulz approach to allocation concealment, and the relation between risk of bias and effect estimates. Design Cross sectional study. Study sample 163 trials in children. Main outcome measures Inter-rater agreement between reviewers assessing trials using the risk of bias tool (weighted κ), time to apply the risk of bias tool compared with other approaches to quality assessment (paired t test), degree of correlation for overall risk compared with overall quality scores (Kendall’s τ statistic), and magnitude of effect estimates for studies classified as being at high, unclear, or low risk of bias (metaregression). Results Inter-rater agreement on individual domains of the risk of bias tool ranged from slight (κ=0.13) to substantial (κ=0.74). The mean time to complete the risk of bias tool was significantly longer than for the Jadad scale and Schulz approach, individually or combined (8.8 minutes (SD 2.2) per study v 2.0 (SD 0.8), PConclusions Inter-rater agreement varied across domains of the risk of bias tool. Generally, agreement was poorer for those items that required more judgment. There was low correlation between assessments of overall risk of bias and two common approaches to quality assessment: the Jadad scale and Schulz approach to allocation concealment. Overall risk of bias as assessed by the risk of bias tool differentiated effect estimates, with more conservative estimates for studies at low risk.This publication has 32 references indexed in Scilit:
- Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological studyBMJ, 2008
- Empirical Evidence for Selective Reporting of Outcomes in Randomized TrialsJAMA, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Statistical methods for assessing the influence of study characteristics on treatment effects in ‘meta‐epidemiological’ researchStatistics in Medicine, 2002
- Assessing allocation concealment and blinding in randomised controlled trials: why bother?Evidence-Based Nursing, 2001
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Bias in Treatment Assignment in Controlled Clinical TrialsNew England Journal of Medicine, 1983